VCs are still showering biotechs with cash, even amid coronavirus

VCs are still showering biotechs with cash, even amid coronavirus

STAT Plus: Venture capitalists are still showering biotechs with cash, even as the coronavirus upends markets 

By KATE SHERIDAN

ADOBE

Venture capitalists are still spending big on biotech companies, even four months after the coronavirus pandemic cratered global markets. 

READ MORE